INKT
NASDAQ HealthcareMiNK Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $10.28 |
|---|---|
| Volume | 132,756 |
| Market Cap | 48.26M |
| Beta | 0.350 |
| RSI (14-Day) | 43.7 |
| 200-Day MA | $12.91 |
| 50-Day MA | $11.54 |
| 52-Week High | $76.00 |
| 52-Week Low | $6.34 |
| Forward P/E | -2.85 |
| Price / Book | -3.50 |
🎯 Investment Strategy Scores
How INKT scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
47/100
High dividend yield + low volatility
🚀 Moon Shot
18/100
High growth potential (high beta + oversold)
🔪 Falling Knife
72/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
61/100
Overbought stocks (potential short candidates)
Find INKT in your text
Paste any text on the homepage — the tool will extract INKT and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.